Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Rheumatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Psoriasis and Psoriatic Disorders Clinical Trials

A listing of Psoriasis and Psoriatic Disorders medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (64) clinical trials

Skin Conditions: Must have moderate to severe plaque-type psoriasis. Name of Medication Being Tested: Etanercept (Enbrel ®) Criteria Needed to be Entered into Study: Children 4 to 17 years of age Must have psoriasis for minimum of 6 months Minimum 10% of total body surface area of psoriasis Must have ...

Phase N/A

If you have been diagnosed with chronic plaque-type psoriasis and are between18 and 70 years old, you may qualify to participate in a research study to evaluate and investigational medication for the treatment of plaque psoriasis. Qualified Study Participants will receive: Study Medications Study related testing Physical exams at no ...

Phase N/A

Treatment of psoriasis, specifically the itch associated with psoriasis, using a topical treatment in patients ages 12 and older with stable mild to moderate plaque psoriasis.

Phase

A study of the efficacy, safety and tolerability of an oral medication for the treatment of pruritus (itching) in adults with plaque psoriasis.

Phase

There is no cure for psoriasis, but there are options. Psoriasis causes an uncomfortable rash that can be embarrassing and difficult to manage. Symptoms often include itchy, dry inflamed patches of skin on areas like the elbows, knees and scalp. If you are struggling to manage symptoms of plaque-type psoriasis ...

Phase

This study is being done to evaluate the safety and tolerability of SNA-120 0.5% ointment applied with calcipotriene 0.005% ointment. This study will also evaluate the efficacy (effectiveness) of SNA-120 0.5% ointment applied with calcipotriene 0.005% ointment in the treatment of psoriasis and the associated symptoms of itching. The results ...

Phase

Psoriasis is a chronic inflammatory disorder primarily affecting the skin and joints that occurs in diverse ethnic groups worldwide.  There is paucity of data on the use of topical medications in dark-skinned individuals. Unique issues in skin of color (SOC) populations, including increased risk of dyspigmentation (hyperpigmentation and hypopigmentation), make ...

Phase

The purpose of this study is to evaluate the safety and efficacy of ixekizumab in pediatric participants with moderate-to-severe plaque psoriasis.

Phase

A research study is evaluating an investigational medication for moderate to severe plaque psoriasis.

Phase N/A

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, 24-Week Study to Assess the Efficacy and Safety of PPC-06 (Tepilamide Fumarate) Extended Release Tablets in Subjects with Moderate-to-Severe Plaque Psoriasis.  

Phase